Publications by authors named "Carol L F Ho"
Ann Acad Med Singap
January 2023
Article Synopsis
- Three doses of SARS-CoV-2 mRNA vaccines are recommended for cancer patients to decrease severe disease risk, especially given that ongoing anti-cancer treatments can impact vaccine effectiveness.
- Researchers evaluated 273 cancer patients (both solid and blood cancers) between July 2021 and March 2022, measuring immune responses after each vaccine dose.
- The study found that while seroconversion rates improved with each dose (35.2% after 1 dose, 79.4% after 2 doses, and 92.4% after 3 doses), patients on active treatment for blood cancers had significantly lower antibody levels compared to those on immunotherapy and chemotherapy.
